Group 1 - The event features a presentation by Reckitt, with representatives Kris and Shannon attending to support the conference [1] - The format of the event includes a fireside chat followed by a breakout session for attendees [2]

Core Viewpoint - Reckitt Benckiser Group PLC (RBGLY) has received an upgrade to Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For the fiscal year ending December 2025, Reckitt Benckiser Group is expected to earn $0.94 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.5% over the past three months [8]. Investment Implications - The upgrade to Zacks Rank 2 positions Reckitt Benckiser Group in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term due to improved earnings outlook [10]. - The Zacks Rank system maintains a balanced approach, with only the top 20% of stocks receiving favorable ratings, indicating a strong earnings estimate revision feature for Reckitt Benckiser Group [9][10].

Group 1 - Carlsberg AS (CABGY) has gained approximately 23.7% year-to-date, significantly outperforming the average gain of 4.5% in the Consumer Staples sector [4] - The Zacks Rank for Carlsberg AS is currently 2 (Buy), indicating a positive earnings outlook with a 1.7% increase in the consensus estimate for full-year earnings over the past quarter [3] - Carlsberg AS belongs to the Beverages - Alcohol industry, which is ranked 178 in the Zacks Industry Rank, and has outperformed this group, which has seen a loss of about 1.5% year-to-date [5] Group 2 - Reckitt Benckiser Group PLC (RBGLY) has also shown strong performance with a year-to-date return of 24%, and it holds a Zacks Rank of 2 (Buy) [4][5] - The Soap and Cleaning Materials industry, to which Reckitt Benckiser belongs, is currently ranked 2, indicating strong performance relative to other industries [6] - Both Carlsberg AS and Reckitt Benckiser Group PLC are highlighted as stocks to watch for investors interested in the Consumer Staples sector due to their solid performance [6]

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY). Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/reckitt-benckiser-group-plc-loss-submission-form-2/?id=159236&from=3 ...

Core Viewpoint - The Rosen Law Firm is reminding purchasers of Reckitt Benckiser Group PLC's American Depositary Shares (ADSs) of a class action lawsuit with a lead plaintiff deadline of August 4, 2025, for those who bought shares between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Class Action Details - Investors who purchased Reckitt ADSs during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The lawsuit alleges that Reckitt failed to warn investors about the increased risk of necrotizing enterocolitis (NEC) in preterm infants due to its cow's milk-based formula, Enfamil, which misled investors regarding the company's business prospects [4]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3].

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group plc for allegedly misleading investors regarding the risks associated with its cow's milk-based formula, Enfamil, which is linked to a serious health risk in premature infants [1][4]. Group 1: Lawsuit Details - The class action lawsuit is filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Reckitt securities between January 13, 2021, and July 28, 2024 [1]. - Investors have until August 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Reckitt failed to adequately warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants consuming its formula [3][4]. Group 2: Allegations Against Reckitt - The lawsuit alleges that Reckitt made misleading statements and omissions regarding its business, financial condition, and prospects during the class period [4]. - Specific allegations include failing to disclose the risks associated with Enfamil, the potential impact on sales, and the exposure to legal claims [4]. - As a result of these omissions, Reckitt's positive statements about its business were deemed materially false and misleading [4]. Group 3: Company Background - Reckitt is a UK-based global consumer goods company facing over 500 product liability lawsuits related to its infant formula [3]. - The lawsuits claim that Reckitt and its competitor Abbott Laboratories did not adequately warn about the risks associated with their cow milk-based formulas [3]. Group 4: Legal Representation - Bragar Eagel & Squire, P.C. is representing the investors in this class action lawsuit and encourages affected individuals to reach out for more information [1][5]. - The firm specializes in representing individual and institutional investors in complex litigation [6].

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.While many investors like to look for momentum i ...

Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser Group plc made false statements regarding the safety of its cow's milk-based formula, Enfamil, particularly concerning the increased risk of necrotizing enterocolitis (NEC) in preterm infants [2]. - It is alleged that these false statements misled investors about the company's sales performance and exposure to legal claims, thus affecting the perceived business operations and prospects of Reckitt Benckiser [2]. Group 2: Investor Participation - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, ensuring no financial obligation to participate [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [4].

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADSs") of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the "Class Period"), of the important August 4, 2025 lead plaintiff deadline. WHAT TO DO NEXT: To join the Reckitt class action, go to https://rosenlegal.com/submit-form/? case_id=40120 or call Phillip Kim, Esq. toll-free at 866-767-3653 or ema ...

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team: h ...